T
Taoyuan Lu
Researcher at Zhengzhou University
Publications - 18
Citations - 418
Taoyuan Lu is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 7 publications receiving 37 citations.
Papers
More filters
Journal ArticleDOI
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Zaoqu Liu,Long Liu,Siyuan Weng,C-C Guo,Qin Dang,Hui-Xian Xu,Libo Wang,Taoyuan Lu,Yuyuan Zhang,Zhenqiang Sun,Xinwei Han +10 more
TL;DR: Li et al. as mentioned in this paper developed a machine learning-based integrative procedure for constructing a consensus immune-related lncRNA signature (IRLS), which is an independent risk factor for overall survival and displays stable and powerful performance, but only demonstrates limited predictive value for relapse-free survival.
Journal ArticleDOI
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Zaoqu Liu,Long Liu,Siyuan Weng,C-C Guo,Qin Dang,Hui-Xian Xu,Libo Wang,Taoyuan Lu,Yuyuan Zhang,Zhenqiang Sun,Xinwei Han +10 more
TL;DR: Li et al. as discussed by the authors developed a machine learning-based integrative procedure for constructing a consensus immune-related lncRNA signature (IRLS), which is an independent risk factor for overall survival and displays stable and powerful performance, but only demonstrates limited predictive value for relapse-free survival.
Journal ArticleDOI
Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
Zaoqu Liu,Taoyuan Lu,Jing Li,Libo Wang,Kaihao Xu,Qin Dang,Long Liu,Chunguang Guo,Dechao Jiao,Zhenqiang Sun,Xinwei Han +10 more
TL;DR: Wang et al. as mentioned in this paper developed and validated a recurrenceassociated immune signature (RAIS) based on global immune genes to identify patients at high recurrence-risk for improving post-operative individual management.
Journal ArticleDOI
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.
TL;DR: In this article, a robust and promising signature termed ferroptosis related risk score (FRRS) was proposed for assessing prognosis and immunotherapy of hepatocellular carcinoma (HCC).
Journal ArticleDOI
Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma.
TL;DR: Wang et al. as mentioned in this paper performed cluster analysis based on the mutational signatures and further investigated the multidimensional heterogeneity of the novel glioma molecular subtypes, the clinical significance and immune landscape of four clusters also investigated.